_id

690f36edccc777a4e85d17a1

Ticker

BMRA

Name

Biomerica Inc

Exchange

NASDAQ

Address

17571 Von Karman Avenue, Irvine, CA, United States, 92614

Country

USA

Sector

Healthcare

Industry

Medical Devices

Currency

USD

Website

https://www.biomerica.com

Description

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Last Close

2.5313

Volume

5253

Current Price

2.58

Change

1.9239126140718283

Last Updated

2025-11-28T13:01:32.704Z

Image

-

Ipo Date

2005-01-03T00:00:00.000Z

Market Cap

7369915

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.996

Sentiment Sources

2

Rating

-

Target Price

13

Strong Buy

-

Buy

-

Hold

-

Sell

-

Strong Sell

-

Current Quarter

2025-08-31

Revenue

1380000

Cost Of Revenue

956000

Gross Profit

424000

Operating Expenses

1542000

Operating Income

-1118000

Interest Expense

-

Pretax Income

5000

Net Income

2000

Eps

0.0007579492772764154

Dividends Per Share

-

Shares Outstanding

2947966

Income Tax Expense

3000

EBITDA

107000

Operating Margin

-81.01449275362319

Total Other Income Expense Net

1123000

Cash

3053000

Short Term Investments

-

Receivables

1205000

Inventories

1473000

Total Current Assets

5899000

Property Plant Equipment

467000

Total Assets

6854000

Payables

681000

Short Term Debt

367000

Long Term Debt

-

Total Liabilities

1699000

Equity

5155000

Depreciation

102000

Change In Working Capital

-550000

Cash From Operations

-268000

Capital Expenditures

0

Cash From Investing

-37000

Cash From Financing

920000

Net Change In Cash

617000

PE

-

PB

1.3206291794374394

ROE

0.03879728419010669

ROA

0.02918004085205719

FCF

-268000

Fcf Percent

-0.19420289855072465

Piotroski FScore

2

Health Score

49

Deep Value Investing Score

8

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

3.5

Net Net Investing Score

3

Quality Investing Score

3

Value Investing Score

7.5

Quarters > 0 > quarter

2025-08-31

Quarters > 0 > income Statement > revenue

1380000

Quarters > 0 > income Statement > cost Of Revenue

956000

Quarters > 0 > income Statement > gross Profit

424000

Quarters > 0 > income Statement > operating Expenses

1542000

Quarters > 0 > income Statement > operating Income

-1118000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

5000

Quarters > 0 > income Statement > net Income

2000

Quarters > 0 > income Statement > eps

0.0007579492772764154

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

2638699

Quarters > 0 > income Statement > income Tax Expense

3000

Quarters > 0 > income Statement > EBITDA

107000

Quarters > 0 > income Statement > operating Margin

-81.01449275362319

Quarters > 0 > income Statement > total Other Income Expense Net

1123000

Quarters > 0 > balance Sheet > cash

3053000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

1205000

Quarters > 0 > balance Sheet > inventories

1473000

Quarters > 0 > balance Sheet > total Current Assets

5899000

Quarters > 0 > balance Sheet > property Plant Equipment

467000

Quarters > 0 > balance Sheet > total Assets

6854000

Quarters > 0 > balance Sheet > payables

681000

Quarters > 0 > balance Sheet > short Term Debt

367000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1699000

Quarters > 0 > balance Sheet > equity

5155000

Quarters > 0 > cash Flow > net Income

2000

Quarters > 0 > cash Flow > depreciation

102000

Quarters > 0 > cash Flow > change In Working Capital

-550000

Quarters > 0 > cash Flow > cash From Operations

-268000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-37000

Quarters > 0 > cash Flow > cash From Financing

920000

Quarters > 0 > cash Flow > net Change In Cash

617000

Quarters > 0 > ratios > PE

0.0007579492772764154

Quarters > 0 > ratios > PB

1.3206291794374394

Quarters > 0 > ratios > ROE

0.03879728419010669

Quarters > 0 > ratios > ROA

0.02918004085205719

Quarters > 0 > ratios > FCF

-268000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.19420289855072465

Quarters > 0 > health Score

49

Quarters > 1 > quarter

2025-05-31

Quarters > 1 > income Statement > revenue

749000

Quarters > 1 > income Statement > cost Of Revenue

993000

Quarters > 1 > income Statement > gross Profit

-244000

Quarters > 1 > income Statement > operating Expenses

1320000

Quarters > 1 > income Statement > operating Income

-1564000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1539000

Quarters > 1 > income Statement > net Income

-1544000

Quarters > 1 > income Statement > eps

-0.15902366064021237

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

9709247

Quarters > 1 > income Statement > income Tax Expense

5000

Quarters > 1 > income Statement > EBITDA

-1460000

Quarters > 1 > income Statement > operating Margin

-208.8117489986649

Quarters > 1 > income Statement > total Other Income Expense Net

25000

Quarters > 1 > balance Sheet > cash

2399000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

731000

Quarters > 1 > balance Sheet > inventories

1490000

Quarters > 1 > balance Sheet > total Current Assets

4875000

Quarters > 1 > balance Sheet > property Plant Equipment

564000

Quarters > 1 > balance Sheet > total Assets

5945000

Quarters > 1 > balance Sheet > payables

295000

Quarters > 1 > balance Sheet > short Term Debt

358000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1840000

Quarters > 1 > balance Sheet > equity

4105000

Quarters > 1 > cash Flow > net Income

-1544000

Quarters > 1 > cash Flow > depreciation

104000

Quarters > 1 > cash Flow > change In Working Capital

629000

Quarters > 1 > cash Flow > cash From Operations

-661000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

4000

Quarters > 1 > cash Flow > cash From Financing

-5000

Quarters > 1 > cash Flow > net Change In Cash

-658000

Quarters > 1 > ratios > PE

-0.15902366064021237

Quarters > 1 > ratios > PB

6.102279478684531

Quarters > 1 > ratios > ROE

-37.61266747868453

Quarters > 1 > ratios > ROA

-25.97140454163162

Quarters > 1 > ratios > FCF

-661000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.8825100133511349

Quarters > 1 > health Score

27

Quarters > 2 > quarter

2025-02-28

Quarters > 2 > income Statement > revenue

1119000

Quarters > 2 > income Statement > cost Of Revenue

1100000

Quarters > 2 > income Statement > gross Profit

19000

Quarters > 2 > income Statement > operating Expenses

1229000

Quarters > 2 > income Statement > operating Income

-1210000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-1167000

Quarters > 2 > income Statement > net Income

-1163000

Quarters > 2 > income Statement > eps

-0.06792654541359731

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

17121436

Quarters > 2 > income Statement > income Tax Expense

-4000

Quarters > 2 > income Statement > EBITDA

-1111000

Quarters > 2 > income Statement > operating Margin

-108.13226094727435

Quarters > 2 > income Statement > total Other Income Expense Net

43000

Quarters > 2 > balance Sheet > cash

3058000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

1268000

Quarters > 2 > balance Sheet > inventories

1655000

Quarters > 2 > balance Sheet > total Current Assets

6204000

Quarters > 2 > balance Sheet > property Plant Equipment

660000

Quarters > 2 > balance Sheet > total Assets

7376000

Quarters > 2 > balance Sheet > payables

632000

Quarters > 2 > balance Sheet > short Term Debt

350000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1842000

Quarters > 2 > balance Sheet > equity

5534000

Quarters > 2 > cash Flow > net Income

-1163000

Quarters > 2 > cash Flow > depreciation

99000

Quarters > 2 > cash Flow > change In Working Capital

-53000

Quarters > 2 > cash Flow > cash From Operations

-1045000

Quarters > 2 > cash Flow > capital Expenditures

4000

Quarters > 2 > cash Flow > cash From Investing

-4000

Quarters > 2 > cash Flow > cash From Financing

1736000

Quarters > 2 > cash Flow > net Change In Cash

686000

Quarters > 2 > ratios > PE

-0.06792654541359731

Quarters > 2 > ratios > PB

7.982165681243224

Quarters > 2 > ratios > ROE

-21.015540296349837

Quarters > 2 > ratios > ROA

-15.767353579175705

Quarters > 2 > ratios > FCF

-1049000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.9374441465594281

Quarters > 2 > health Score

27

Quarters > 3 > quarter

2024-11-30

Quarters > 3 > income Statement > revenue

1636000

Quarters > 3 > income Statement > cost Of Revenue

1199000

Quarters > 3 > income Statement > gross Profit

437000

Quarters > 3 > income Statement > operating Expenses

1430000

Quarters > 3 > income Statement > operating Income

-993000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-953000

Quarters > 3 > income Statement > net Income

-950000

Quarters > 3 > income Statement > eps

-0.05548600012288689

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

17121436

Quarters > 3 > income Statement > income Tax Expense

-3000

Quarters > 3 > income Statement > EBITDA

-993000

Quarters > 3 > income Statement > operating Margin

-60.69682151589242

Quarters > 3 > income Statement > total Other Income Expense Net

40000

Quarters > 3 > balance Sheet > cash

2372000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

1326000

Quarters > 3 > balance Sheet > inventories

1789000

Quarters > 3 > balance Sheet > total Current Assets

5945000

Quarters > 3 > balance Sheet > property Plant Equipment

755000

Quarters > 3 > balance Sheet > total Assets

7274000

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

342000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

2160000

Quarters > 3 > balance Sheet > equity

5114000

Quarters > 3 > cash Flow > net Income

-950000

Quarters > 3 > cash Flow > depreciation

100000

Quarters > 3 > cash Flow > change In Working Capital

219000

Quarters > 3 > cash Flow > cash From Operations

-791000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-33000

Quarters > 3 > cash Flow > cash From Financing

380000

Quarters > 3 > cash Flow > net Change In Cash

-448000

Quarters > 3 > ratios > PE

-0.05548600012288689

Quarters > 3 > ratios > PB

8.637720938599923

Quarters > 3 > ratios > ROE

-18.576456785295267

Quarters > 3 > ratios > ROA

-13.06021446246907

Quarters > 3 > ratios > FCF

-791000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.4834963325183374

Quarters > 3 > health Score

27

Valuation > metrics > PE

0.0007579492772764154

Valuation > metrics > PB

1.3206291794374394

Valuation > final Score

100

Valuation > verdict

50.0% Undervalued

Profitability > metrics > ROE

0.03879728419010669

Profitability > metrics > ROA

0.03390405153415833

Profitability > metrics > Net Margin

0.0014492753623188406

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.32958292919495635

Risk > metrics > Interest Coverage

-10.96078431372549

Risk > final Score

16

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.6288167938931295

Liquidity > metrics > Quick Ratio

4.223282442748092

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-19

Prev Risks > 1

-26

Prev Risks > 2

-39

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:17:19.610Z